| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Traws Pharma, Inc. | Chief Medical Officer | Common Stock | 113,919 | $291,632 | $2.56 | 12 Dec 2025 | Direct |
| Traws Pharma, Inc. | Chief Medical Officer | Stock Option (right to purchase) | 65,676 | 12 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TRAW | Traws Pharma, Inc. | 12 Dec 2025 | 2 | $0 | 4 | Chief Medical Officer | 16 Dec 2025, 18:15 |
| TRAW | Traws Pharma, Inc. | 12 Oct 2025 | 1 | $0 | 4 | Chief Medical Officer | 15 Oct 2025, 20:09 |
| TRAW | Onconova Therapeutics, Inc. | 01 Apr 2024 | 1 | $0 | 4 | Acting Chief Medical Officer | 03 Apr 2024, 20:07 |
| TRAW | Onconova Therapeutics, Inc. | 01 Apr 2024 | 0 | $0 | 3 | Acting Chief Medical Officer | 03 Apr 2024, 19:55 |